The STIKO now generally recommends vaccination as well as booster vaccination for children and adolescents from 12 years of age. For children from 5 years of age, the STIKO currently recommends the booster vaccination only under special conditions. For more information, see the question What should be considered when vaccinating children and adolescents?

Especially in view of the spread of the Omikron variant, the STIKO has updated its recommendation for booster vaccination with regard to the vaccination interval: The booster vaccination can be given as early as three months after the last vaccine dose of the basic immunisation. The background to this recommendation is the goal of preventing severe courses of COVID-19 and reducing transmission, especially of the spreading Omikron variant, through this accelerated booster vaccination campaign and the shortened vaccination interval.

At the following times, the 1st booster vaccination is recommended for the respective groups of persons:

  • All persons aged 18 years and older: from 3 months after complete basic immunisation.
  • Pregnant women of any age from the second trimester of pregnancy: from 3-6 months after complete basic immunisation with the mRNA vaccine Comirnaty.
  • 5- to 11-year-old children with pre-existing conditions: from 6 months after basic immunisation.
  • 5- to 11-year-old children with immunodeficiency: from 3 months after completed basic immunisation.
  • 12- to 17-year-old children and adolescents: from 3 to 6 months after basic immunisation.
    Children and adolescents with pre-existing conditions should receive their booster vaccination as early as possible to reduce symptomatic SARS-CoV-2 infections and illnesses as much as possible during the current wave of infections. For children and adolescents without pre-existing conditions, the STIKO recommends a rather longer vaccination interval of up to 6 months, as this provides better long-term protection for immunological reasons.
  • Persons with a severe immune deficiency according to table 9 of the current STIKO recommendations.
  • For recovered persons or persons who become infected with the corona virus before, during or after a vaccination series, see question: "How should persons be vaccinated who have already had a corona infection?"

On 17 February, the Standing Commission on Vaccination recommended a second booster vaccination for groups at particular health risk and exposure (see 18th update of the COVID-19 vaccination recommendation). People aged 70 years and older, residents and persons cared for in care facilities, and people with immunodeficiency aged 5 years and older are recommended a booster no earlier than three months after the first booster vaccination. Registration for a booster vaccination is already possible from the age of 60 at your own request.

People employed in medical and care facilities are recommended to receive the second booster vaccination at least six months after the first booster vaccination.

The STIKO recommends a booster vaccination with an mRNA vaccine in a minimum interval of 3 months after the completed basic immunization for persons aged 18 years and older who have been vaccinated with Nuvaxovid. Currently, there is no approval for Nuvaxovid for booster vaccination. According to the STIKO, Nuvaxovid® can be offered as a booster vaccination in individual cases after medical clarification if there are contraindications to mRNA-COVID-19 vaccines. This requires the presentation of a general practitioner's certificate to the vaccination center, which clearly states that Novavax should be vaccinated. The indication of a disease diagnosis alone is not sufficient.

If you would like the Nuvaxovid vaccine for a second vaccination or booster, you must indicate this as part of the registration process.